Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts
International Journal of Laboratory Hematology · 2024
DOI: 10.1111/ijlh.14216 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2024. Verfasst von Rahaf Mahmoud Altahan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: von Willebrand Diseases, Thrombocytopenia, Blood Platelet Disorders, Platelet-Rich Plasma. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: McMaster University.
Abstract (Originalsprache)
Introduction
Light transmission aggregometry (LTA) is important for diagnosing platelet function disorders (PFD) and von Willebrand disease (VWD) affecting ristocetin‐induced platelet aggregation (RIPA). Nonetheless, data is lacking on the utility of LTA for investigating thrombocytopenic patients and platelet rich plasma samples with low platelet counts (L‐PRP). Previously, we developed a strategy for diagnostic LTA assessment of L‐PRP that included: (1) acceptance of referrals/samples, regardless of thrombocytopenia severity, (2) tailored agonist selection, based on which are informative for L‐PRP with mildly or severely low platelet counts, and (3) interpretation of maximal aggregation (MA) using regression‐derived 95% confidence intervals, determined for diluted control L‐PRP (C‐L‐PRP).
Methods
To further evaluate the L‐PRP LTA strategy, we evaluated findings for a subsequent patient cohort.
Results
Between 2008 and 2021, the L‐PRP strategy was applied to 211 samples (11.7% of all LTA samples) from 192 unique patients, whose platelet counts (median [range] × 10 9 /L) for blood and L‐PRP were: 105 [13–282; 89% with thrombocytopenia] and 164 [17–249], respectively. Patient‐L‐PRP had more abnormal MA findings than simultaneously tested C‐L‐PRP ( p ‐values
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
- Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Riyadh, Saudi Arabia.
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.
ORCID-Profile: Rahaf Mahmoud Altahan, Natalie Mathews, Alex Bourguignon, Subia Tasneem, Donald M Arnold, Wendy Lim, Catherine P M Hayward
Förderung
- McMaster University
Zitieren
APA
Altahan, R. M., Mathews, N., Bourguignon, A., Tasneem, S., Arnold, D. M., Lim, W., & Hayward, C. P. M. (2024). Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14216
Vancouver
Altahan RM, Mathews N, Bourguignon A, Tasneem S, Arnold DM, Lim W, et al. Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts. International Journal of Laboratory Hematology. 2024. doi:10.1111/ijlh.14216
BibTeX
@article{Altahan2024,
author = {Altahan, Rahaf Mahmoud and Mathews, Natalie and Bourguignon, Alex and Tasneem, Subia and Arnold, Donald M and Lim, Wendy and Hayward, Catherine P M},
title = {Evaluation of a diagnostic platelet aggregation test strategy for platelet rich plasma samples with low platelet counts},
journal = {International Journal of Laboratory Hematology},
year = {2024},
doi = {10.1111/ijlh.14216}
}
EUVIMED